After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, NAGE falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Niagen Bioscience Inc is $549.07M. A total of 0.84 million shares were traded on the day, compared to an average of 1.06M shares.
In the most recent transaction, Pamir Ozan bought 4,465 shares of NAGE for 6.81 per share on Nov 14 ’25. After the transaction, the Chief Financial Officer now owns 7,372 company shares. In a previous transaction on Nov 14 ’25, Pamir Ozan bought 2,220 shares at 6.85 per share. NAGE shares that Chief Financial Officer owns now total 2,220.
Among the insiders who bought shares, Lopez Carlos Luis acquired of 273 shares on Mar 07 ’25 at a per-share price of $7.86. This resulted in the SVP, General Counsel holding 2,251 shares of NAGE after the transaction. In another insider transaction, Jaksch Frank L Jr sold 37,161 shares at $6.19 per share on Dec 13 ’24. Company shares held by the Director now total 244,179.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, NAGE has a high of $14.69 and a low of $5.16.
As of this writing, NAGE has an earnings estimate of $0.01 per share for the current quarter. EPS was calculated based on a consensus of 2.0 estimates, with a high estimate of $0.02 per share and a lower estimate of $0.01. The company reported an EPS of $0.03 in the last quarter
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. NAGE’s latest balance sheet shows that the firm has $28.02M in Cash & Short Term Investments as of fiscal 2021. There were $4.70M in debt and $17.61M in liabilities at the time. Its Book Value Per Share was $0.89, while its Total Shareholder’s Equity was $31.73M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NAGE is Buy with a score of 4.60.
